GeminIQ Website Logo

Viewing ANEB free

Start free trial

Subscribe for full history, 50+ metrics, screener, watchlist...

Anebulo Pharmaceuticals, Inc.

ANEB

Companies in Pharmaceutical Preparations

LLYJNJABBVMRKABTPFE

Anebulo Pharmaceuticals, Inc. (ANEB) — SEC Financial Statements & Analysis

Anebulo Pharmaceuticals, Inc. (ANEB) files its annual 10-K and quarterly 10-Q reports directly with the SEC. The financial data below is sourced as-filed from EDGAR — balance sheet, income statement, and cash flow as reported, without normalization or third-party adjustments.

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

Values in Millions ($)
2025-12-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
2023-03-31
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Data beyond 3 years is for subscribers only.

Unlock 17+ years of financial data

Start 7-day free trial
Subscriber-only column
Assets
Cash And Cash Equivalents At Carrying Value
9101213151357911-
Cash
----------1114
Assets Current
Assets Current
9111214152457-12-
Grants Receivable
----00------
Prepaid Expense Current
000100000100
Assets Noncurrent
Other Assets Noncurrent
000001111---
Assets
911121416246891214
Liabilities And Stockhold…
Accounts Payable Current
110000000111
Liabilities Current
Accrued Liabilities Current
100010011011
Liabilities
110111011111
Common Stock Value
000000000000
Stockholders Equity
Additional Paid In Capital
868686858569696969686868
Stockholders Equity
810121315245681113
Retained Earnings Accumulated Deficit
-78-76-74-72-70-68-65-64-62-60-57-55
Liabilities And Stockholders Equity
911121416246891214
Preferred Stock Par Or Stated Value Per Share
0.0010.0010.0010.0010.0010.0010.0010.0010.0010.0010.0010.001
Preferred Stock Shares Authorized
222222222202
Preferred Stock Shares Issued
000000000000
Preferred Stock Shares Outstanding
000000000000
Common Stock Par Or Stated Value Per Share
0.0010.0010.0010.0010.0010.0010.0010.0010.0010.0010.0010.001
Common Stock Shares Authorized
757575505050505040404040
Common Stock Shares Issued
414141414126262626262626
Shares Outstanding
414141414126262626262626

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

0/5
Search a metric to start building a table

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

0/1
Search a metric to start building a visual

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

Fiscal Year
Q1 1 Month
Q1 2 Month
Q1 3 Month
Q2 1 Month
Q2 2 Month
Q2 3 Month
Q3 1 Month
Q3 2 Month
Q3 3 Month
Q4 1 Month
Q4 2 Month
Q4 3 Month
2026-4.64%-52.32%-55.70%-4.21%57.89%-3.16%------
2025-6.77%6.45%-0.90%-19.55%-23.31%-13.53%10.77%72.31%192.31%13.64%-2.69%-10.33%
20249.91%13.21%20.75%14.34%7.75%14.34%-8.05%9.75%-15.25%6.00%-14.16%-24.32%
2023------7.96%1.08%-5.63%-25.00%-34.45%-28.96%

Data beyond 3 years is for subscribers only.

Unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data and 50+ calculated metrics

Start free trial

Performance and Valuation Metrics

Metrics
2025-12-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
2023-03-31
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Data beyond 3 years is for subscribers only.

Unlock 17+ years of financial data

Start 7-day free trial
Subscriber-only column
Leverage & Debt
Interest Coverage TTM
-
-
-
-
-134.09
-89.34
-90.77
-103.38
-334.90
-
-
-
Efficiency & Turnover
Asset Turnover TTM
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
-
0.00
-
Per Share Metrics
Diluted EPS TTM
-0.19
-0.21
-0.25
-0.19
-0.28
-0.31
-0.32
-0.36
-0.41
-0.45
-0.47
-0.45
Free Cash Flow Per Share TTM
-0.14
-0.14
-0.19
-0.16
-0.24
-0.27
-0.31
-0.34
-0.37
-0.40
-0.39
-0.34
Dividend Per Share TTM
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Growth Metrics
Net Income Growth (1Y)
4.06%
6.57%
3.45%
-17.73%
-26.92%
-31.72%
-30.09%
-19.14%
-1.38%
47.15%
71.89%
-72.74%
EPS Growth (1Y)
-30.56%
-32.73%
-21.01%
-48.07%
-31.25%
-32.51%
-32.12%
-20.07%
-1.97%
34.42%
60.03%
-75.18%
Valuation Metrics
P/E TTM
-5.20
-12.17
-5.74
-6.95
-6.01
-6.32
-8.60
-7.96
-5.95
-6.75
-5.02
-6.43
P/B
5.23
10.55
4.18
3.97
3.08
26.36
18.49
14.93
9.62
9.40
5.56
5.74
Market Cap
41.50M
102.71M
48.70M
53.41M
46.06M
50.05M
70.49M
74.43M
62.41M
78.31M
58.93M
74.34M
Enterprise Value
32.45M
92.36M
37.07M
40.13M
31.06M
48.65M
67.40M
69.28M
55.77M
69.79M
47.68M
60.17M
Calculated Values
Free Cash Flow TTM
-5.84M
-5.93M
-6.35M
-6.75M
-6.65M
-7.05M
-8.09M
-8.89M
-9.58M
-10.38M
-9.68M
-8.83M
Net Debt
-9.04M
-10.35M
-11.63M
-13.28M
-15.00M
-1.40M
-3.09M
-5.15M
-6.64M
-8.52M
-11.25M
-14.16M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2024-12-23Purchase
Owner: English, Aron R., 22Nw Fu…
Title: -
Shares: 10,101,010
Price/Share: $0.99
Value: $9,999,999.90
Shares Owned: 15,467,300
Relationship: TenPercentOwner
Ownership: Indirect

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart
2025-12-31
54.06%
Inst. Shares: 22,208,686
Shares Outstanding: 41,084,731
2025-09-30
54.08%
Inst. Shares: 22,219,763
Shares Outstanding: 41,084,731
2025-06-30
66.80%
Inst. Shares: 22,591,946
Shares Outstanding: 33,820,306
2025-03-31
55.00%
Inst. Shares: 22,595,103
Shares Outstanding: 41,084,731
2024-12-31
82.33%
Inst. Shares: 22,570,347
Shares Outstanding: 27,415,430

Research Faster.
Invest Smarter.

Start 7-day free trial

Anebulo Pharmaceuticals, Inc. (ANEB) financial data sourced directly from SEC EDGAR filings — including the latest 10-K annual report, 10-Q quarterly filings, insider transactions (SEC Form 4), institutional ownership (SEC Form 13F), Earning Marker Reaction Heat Map and 50+ calculated financial metrics like Price to Earnings Ratio (P/E), Return on Equity (ROE), Debt to Equity (D/E), Free Cash Flow Per Share (FCF/S), and Return on Invested Capital (ROIC). Unlike platforms that rely on third-party data aggregators, GeminIQ parses raw SEC filings directly — delivering institutional-grade accuracy at a fraction of the cost of Bloomberg Terminal or S&P Capital IQ.